StockWatch
·

Vera Therapeutics, Inc.

Ticker: 1831828

values in millions
PeriodQ3 FY26
INCOME
Revenue10.28
Total Income10.28
EXPENSES
Expenditure105.98
PROFIT
Net Profit-93.71
KEY METRICS
OPM %-100.00%
NPM %-100.00%
EPS-1.30

Corporate Events

Board MeetingVERA
2026
9Jul

Board Meeting

Chief Regulatory Officer Transition — William Turner to reti…

SEC Filing ↗
Board MeetingVERA
2026
21May

Board Meeting

2026 Annual Meeting of Stockholders to elect Class II Direct…

SEC Filing ↗